相关实验视频

Updated: Jun 13, 2025

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Published on: November 11, 2016

释放iPSC衍生的免疫细胞的潜力:为尖端免疫疗法设计iNK和iT细胞

Minggang Fang¹, Alexander Allen¹, Chong Luo¹

¹Cell Therapy, Tome Biosciences, Watertown, MA, United States.

Frontiers in immunology

|September 16, 2024

概括

工程诱导多能干细胞 (iPSCs) 提供了新一代细胞免疫疗法. 先进的基因编辑策略增强iPSC衍生的免疫细胞,以提高癌症治疗的有效性和安全性.

科学领域:

干细胞生物学干细胞生物学
免疫治疗是一种免疫疗法.
基因组工程是基因组工程.

背景情况:

诱导多能干细胞 (iPSC) 对于细胞疗法非常有价值,因为它们具有差异化潜力,可扩展性和异种性使用.
在iPSC衍生的免疫细胞 (iNK和iT细胞) 的进展在临床前和临床癌症研究中显示出希望.
目前基于细胞的免疫疗法面临的挑战包括安全性,有效性和瘤微环境的耐药性.

研究的目的:

概述iPSC的12个工程策略,以解决当前基于细胞的免疫疗法的局限性.
突出高级基因组编辑的潜力,以创建复杂的iPSC衍生细胞产品.
探索如何设计iPSC可以导致下一代免疫疗法.

主要方法:

利用先进的基因组编辑技术,精确插入大型DNA序列.
实施安全开关,避免GvHD,有针对性的交付和增强持久性的战略.
工程iPSC用于改善茎状,代谢适应性,定位和克服瘤抑制.

主要成果:

在模型和试验中,通过iPSC衍生的iNK和iT细胞证明了对癌细胞的强大杀死.
启用多重基因修改 (淘汰和插入) 没有DNA双链断裂.
促进了复杂的细胞疗法产品的快速和高效的工程.

结论:

改造的iPSCs,特别是iNK和iT细胞,代表了细胞免疫疗法的重大进步.
先进的基因编辑技术允许在开发细胞疗法的前所未有的定制和效率.
整合iPSC技术和基因编辑预示着下一代癌症免疫疗法的新时代.

关键词:

不同化的差异化差异化.工程策略工程策略 iNKNK 在线观看这就是 iPSC 的意义.这是一个很棒的节目.下一代免疫疗法下一代免疫疗法

更多相关视频

Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells

Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells

Published on: October 24, 2019

Directed Differentiation of Induced Pluripotent Stem Cells towards T Lymphocytes

Directed Differentiation of Induced Pluripotent Stem Cells towards T Lymphocytes

Published on: May 14, 2012

相关概念视频

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.